Application 090261
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM | LEVETIRACETAM | TABLET;ORAL | 1GM | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-5619 | Levetiracetam | levetiracetam | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5619 | Levetiracetam | levetiracetam | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5619 | Levetiracetam | levetiracetam | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5619 | Levetiracetam | levetiracetam | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5619 | Levetiracetam | levetiracetam | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 51079-860 | Levetiracetam | levetiracetam | Mylan Institutional Inc. | ANDA | Current |
| 51079-860 | Levetiracetam | levetiracetam | Mylan Institutional Inc. | ANDA | Current |